|
|
|
|
Syros Pharmaceuticals Inc (NASDAQ: SYRS) |
|
|
|
|
|
Syros Pharmaceuticals Inc 's ROE per quarter
Return on Equity, Quarterly Results, Trends, Rankings, Statistics
What is ROE for Syros Pharmaceuticals Inc in the third quarter 2024?
Syros Pharmaceuticals Inc recorded a cumulative net loss of $-98 million during 12 months ending in the third quarter 2024, resulting in a negative return on equity (ROE) of -2746.84%.
Within the Major Pharmaceutical Preparations industry 380 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2024 from 3673 to 3824.
What is ROE?
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| Return On Equity |
(Sep 30 2024)
III. Quarter |
(Jun 30 2024)
II. Quarter |
(Mar 31 2024)
I. Quarter |
(Dec 31 2023)
IV. Quarter |
(Sep 30 2023)
III. Quarter |
| Y / Y Equity Change |
- |
- |
-85.9 % |
-86.96 % |
- |
| Y / Y Net Income Change |
- |
- |
- |
- |
- |
| Net Income (TTM) in Millions |
-98 |
-132 |
-144 |
-165 |
-105 |
| Return On Equity (TTM) |
-2746.84 % |
-853.34 % |
-409.15 % |
-282.58 % |
-122.04 % |
| SYRS's Total
Ranking |
# 3824 |
# 3673 |
# 0 |
# 0 |
# 3604 |
| Equity (TTM) in Millions |
-11 |
-6 |
15 |
17 |
36 |
| Seq. Equity Change |
- |
- |
-9.63 % |
-54.1 % |
-50.43 % |
| Seq. Net Income Change |
- |
- |
- |
- |
- |
| Return
On Equity Company Ranking |
| Within: |
No. |
| Industry |
# 381 |
| Sector |
# 796 |
| Overall |
# 3824 |
| Return On Equity Statistics |
| High |
Average |
Low |
-63.8 % |
-232.2 % |
-2746.84 % |
| (Sep 30 2018) |
|
(Sep 30 2024) |
| SYRS Annual Return On Equity |
(Dec 31 2023)
2023 |
(Dec 31 2022)
2022 |
(Dec 31 2021)
2021 |
(Dec 31 2020)
2020 |
(Dec 31 2019)
2019 |
| Total Equity in Millions |
17 |
128 |
85 |
91 |
79 |
| Y / Y Equity Change |
-86.96 % |
49.89 % |
-5.89 % |
14.36 % |
0.76 % |
| Net Income in Millions |
-165 |
-95 |
-87 |
-84 |
-75 |
| Y / Y Net Income Change |
- |
- |
- |
- |
- |
| Return On Equity |
-987.72 % |
-74.1 % |
-101.57 % |
-92.81 % |
-95.27 % |
| Companies with similar Return On Equity at Sep 30 2024, within Healthcare Sector | ROE |
|
Date modified: 2024-12-29T19:28:16+00:00
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
